A new liposomal formulation for antisense oligodeoxynucleotides with small size, high incorporation efficiency and good stability

This publication has 33 references indexed in Scilit:

• A comparison of in vivo gene delivery methods for antisense therapy in ligament healing
  Gene Therapy, 1998
• Liposomes as a carrier for intracellular delivery of antisense oligonucleotides: a real or magic bullet?
  Journal of Controlled Release, 1996
• Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol.
  Proceedings of the National Academy of Sciences, 1995
• Pharmacokinetics of antisense oligodeoxyribonucleotides (cyclin B1 and CDC 2 kinase) in the vessel wall in vivo: enhanced therapeutic utility for restenosis by HVJ-liposome delivery
  Gene, 1994
• Current concepts in antisense drug design
  Journal of Medicinal Chemistry, 1993
• Inhibition of HIV-1 Replication in Cultured Cells with Antisense Oligonucleotides Encapsulated in Immunoliposomes
  Antisense Research and Development, 1993
• Inhibition of the Friend Retrovirus by Antisense Oligonucleotides Encapsulated in Liposomes: Mechanism of Action
  Pharmaceutical Research, 1993
• Intracellular availability of unmodified, phosphorothioated and liposomally encapsulated oligodeoxynucleotides for antisense activity
  Nucleic Acids Research, 1992
• Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
  FEBS Letters, 1990
• Antibody-targeted liposomes containing oligodeoxyribonucleotides complementary to viral RNA selectively inhibit viral replication.
  Proceedings of the National Academy of Sciences, 1990